139 related articles for article (PubMed ID: 124700)
21. Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children.
Burgio GR; Lanzavecchia A; Maccario R; Vitiello A; Plebani A; Ugazio AG
Clin Exp Immunol; 1978 Aug; 33(2):298-301. PubMed ID: 152683
[TBL] [Abstract][Full Text] [Related]
22. [Antibodies to thymocytes in the serum of Down's syndrome patients].
Domashneva IV; Shvarts EI; Kushner SG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(10):1424-7. PubMed ID: 158926
[No Abstract] [Full Text] [Related]
23. Monoclonal antibodies to CD18 and CD11A (LFA-1) distinguish Down's syndrome (trisomy 21) from normal lymphoblastoid cells.
Robson AJ; Taylor GM; D'Souza SW
Dis Markers; 1989; 7(3):169-80. PubMed ID: 2569955
[TBL] [Abstract][Full Text] [Related]
24. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis.
Fong CT; Brodeur GM
Cancer Genet Cytogenet; 1987 Sep; 28(1):55-76. PubMed ID: 2955886
[TBL] [Abstract][Full Text] [Related]
25. T cell response to anti-CD3 antibody in Down's syndrome.
Bertotto A; Arcangeli C; Crupi S; Marinelli I; Gerli R; Vaccaro R
Arch Dis Child; 1987 Nov; 62(11):1148-51. PubMed ID: 2961309
[TBL] [Abstract][Full Text] [Related]
26. Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system?
Cuadrado E; Barrena MJ
Clin Immunol Immunopathol; 1996 Mar; 78(3):209-14. PubMed ID: 8605695
[TBL] [Abstract][Full Text] [Related]
27. Down's syndrome and celiac disease: the prevalence of high IgA-antigliadin antibodies and HLA-DR and DQ antigens in trisomy 21.
Castro M; Crinò A; Papadatou B; Purpura M; Giannotti A; Ferretti F; Colistro F; Mottola L; Digilio MC; Lucidi V
J Pediatr Gastroenterol Nutr; 1993 Apr; 16(3):265-8. PubMed ID: 8492253
[TBL] [Abstract][Full Text] [Related]
28. Free interleukin-2 receptors in children with trisomy 21 (Down's syndrome) and different levels of periodontal disease.
Cutando-Soriano A; Gómez-Moreno G; Bravo M
Int J Paediatr Dent; 1998 Sep; 8(3):177-80. PubMed ID: 17294624
[TBL] [Abstract][Full Text] [Related]
29. Amniotic fluid levels of CA 19.9 and CA 15.3 in normal and Down's syndrome pregnancies.
Noci I; Borri P; Biagiotti R; Cariati E; Branconi F; Torricelli F; Cappelli G; D'Agata A
J Perinat Med; 1995; 23(3):237-41. PubMed ID: 8568617
[TBL] [Abstract][Full Text] [Related]
30. Australia antigen and Down's syndrome.
Dallapiccola B
Lancet; 1971 Sep; 2(7723):548. PubMed ID: 4105695
[No Abstract] [Full Text] [Related]
31. DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome.
Agarwal SS; Blumberg BS; Gerstley BJ; London WT; Sutnick AI; Loeb LA
J Clin Invest; 1970 Jan; 49(1):161-9. PubMed ID: 4188267
[TBL] [Abstract][Full Text] [Related]
32. Is disomic homozygosity at the APECED locus the cause of increased autoimmunity in Down's syndrome?
Shield JP; Wadsworth EJ; Hassold TJ; Judis LA; Jacobs PA
Arch Dis Child; 1999 Aug; 81(2):147-50. PubMed ID: 10490523
[TBL] [Abstract][Full Text] [Related]
33. Atypicality or specific screen: which is better at detecting non-Down's chromosomal anomalies?
Reynolds TM
Ann Clin Biochem; 1997 Nov; 34 ( Pt 6)():675-80. PubMed ID: 9367007
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility to autoimmune thyroiditis in Down's syndrome is associated with the major histocompatibility class II DQA 0301 allele.
Nicholson LB; Wong FS; Ewins DL; Butler J; Holland A; Demaine AG; McGregor AM
Clin Endocrinol (Oxf); 1994 Sep; 41(3):381-3. PubMed ID: 7955446
[TBL] [Abstract][Full Text] [Related]
35. Molecular diagnosis of Down's syndrome.
Wang S; Jia C; Ren G; Ma Y; Lü W; Ding F; Han J
Chin Med J (Engl); 2003 Nov; 116(11):1773-5. PubMed ID: 14642158
[TBL] [Abstract][Full Text] [Related]
36. Antenatal reflex DNA screening for trisomy 18 and trisomy 13 in addition to Down's syndrome.
Bestwick JP; Wald NJ
J Med Screen; 2016 Dec; 23(4):171-174. PubMed ID: 26790709
[TBL] [Abstract][Full Text] [Related]
37. Down's syndrome in twins with discordant HL-A phenotypes.
Hirsch W; Bender K; Mayerova A; Riehm H; Ritter H; Tariverdian G
Humangenetik; 1974; 21(3):255-62. PubMed ID: 4277080
[No Abstract] [Full Text] [Related]
38. Arthropathy of Down's syndrome.
Yancey CL; Zmijewski C; Athreya BH; Doughty RA
Arthritis Rheum; 1984 Aug; 27(8):929-34. PubMed ID: 6235815
[TBL] [Abstract][Full Text] [Related]
39. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
Hann HW; Deacon JC; London WT
Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
[TBL] [Abstract][Full Text] [Related]
40. Immunological and purine enzyme studies on hyperuricaemic and normouricaemic patients with Down's syndrome.
Watts RW; Perera YS; Allsop J; Newton C; Platts-Mills TA; Webster AD
Clin Exp Immunol; 1979 Jun; 36(3):355-63. PubMed ID: 158448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
